Abiopharma

News list

Landis John B. 🟢 acquired 40.0K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Full text

News bot Jan. 6, 2026, 9:29 p.m.
🔍 Landis John B. (Executive)

Company: EyePoint, Inc. (EYPT)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 40,000
Detailed Transactions and Holdings:
- Acquired 40,000 shares of Stock Option (Right to Buy) at $17.48 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | Exercise: 2027-01-02 | equity_swap_involved: false | shares_owned_after: 40,000.00 | transaction_form_type: 4